Is this you? Create Your Porfile
Avatar

Zweifel Mark James

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Zweifel Mark James is active.

Explore More

Publication

Featured researches published by Zweifel Mark James.

Archive | 2012

Glycopeptide deriveatives as antibiotic

Cooper Robin D G; Huff Bret Eugene; Nicas Thalia I; Quatroche John Thomas; Rodriguez Michael J; Snyder Nancy J; Staszak Michael Alexander; Thompson Richard C; Wilkie Stephen C; Zweifel Mark James

Archive | 2007

DERIVATE VON GLYKOPEPTIDANTIBIOTIKA

Cooper Robin David Grey; Huff Bret Eugene; Nicas Thalia Ioanna; Quatroche John Thomas; Rodriguez Michael John; Snyder Nancy June; Staszak Michael Alexander; Thompson Richard Craig; Wilkie Stephen Charles; Zweifel Mark James

Archive | 2007

Antibiotiske glykopeptidderivater, fremgangsmate for fremstilling derav, samt farmasoytiske preparater inneholdende derivatene.

Cooper Robin David Grey; Rodriguez Michael John; Thompson Richard Craig; Huff Bret Eugene; Staszak Michael Alexander; Nicas Thalia Ioanna; Snyder Nancy June; Zweifel Mark James; Quatroche John Thomas; Wilkie Stephen Charles

Archive | 2006

GLYCOPEPTIDE ANTIBIOTIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF

Cooper Robin David Grey; Staszak Michael Alexander; Nicas Thalia Ioanna; Rodriguez Michael John; Snyder Nancy June; Thompson Richard Craig; Zweifel Mark James; Huff Bret Eugene; Quatroche John Thomas; Wilkie Stephen Charles

Archive | 2004

Glycopeptide antibiotic derivative and pharmaceutical composition in which the derivative is comprised

Nicas Thalia Ioanna; Rodriguez Michael John; Snyder Nancy June; Thompson Richard Craig; Zweifel Mark James; Wilkie Stephen Charles; Huff Bret Eugene; Quatroche John Thomas; Staszak Michael Alexander; Cooper Robin David Grey

Archive | 2004

Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection

Thompson Richard Craig; Wilkie Stephen Charles; Zweifel Mark James

Archive | 2003

N-acilação seletiva de análogos de glicopeptìdeo a82846

Thompson Richard Craig; Wilkie Stephen Charles; Zweifel Mark James

Archive | 2003

AGENTES ANTIFUNGICOS PEPTIDICOS CICLICOS.

Jamison James Andrew; Rodriguez Michael John; Lagrandeur Lisa Marie Hammond; Turner William Wilson; Zweifel Mark James

Archive | 2003

Selective N-acylation process of A82846 glycopeptide analogs

Thompson Richard Craig; Wilkie Stephen Charles; Zweifel Mark James

Archive | 2003

Glycopeptid-Antibiotika-Derivate

Cooper Robin David Grey; Huff Bret Eugene; Nicas Thalia Ioanna; Quatroche John Thomas; Rodriguez Michael John; Snyder Nancy June; Staszak Michael Alexander; Thompson Richard Craig; Wilkie Stephen Charles; Zweifel Mark James

Explore More

Collaboration

Dive into the Zweifel Mark James's collaboration.

Top Co-Authors
Avatar

Rodriguez Michael John

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Thompson Richard Craig

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Snyder Nancy June

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Wilkie Stephen Charles

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Cooper Robin David Grey

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Huff Bret Eugene

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Quatroche John Thomas

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Nicas Thalia Ioanna

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Staszak Michael Alexander

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Chen Shu Hui

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge